NICE logo

NICE NICE Ltd.

NASDAQ · Software - Application · Technology

$102.26
-2.99 (-2.84%)

NICE Ltd., together with its subsidiaries, provides AI-powered cloud platforms for customer engagement, and financial crime and compliance in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Customer Engagement; and Financial Crime and Compliance. The Customer Engagement segment provides CXone Mpower platform for organizations to automate servi…

Market Cap: $5.99Bwww.nice.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

107
107
Aug 17Aug 17

Quote

Day Range
$101.74 – $106.78
52-Week Range
$83.10 – $153.68
Volume
$414.0K
Market Cap
$5.99B
50-Day Avg
$95.14
200-Day Avg
$106.63
Prev Close
$105.25
Open
$106.64

Valuation & Ratios

P/E Ratio
11.51
EPS
$9.82
P/B Ratio
1.82
P/S Ratio
2.39
Debt/Equity
0.04
Current Ratio
1.55
Dividend Yield
+0.0%
Gross Margin
+66.4%

Returns & Efficiency

Return on Equity
+15.8%
Return on Assets
+12.0%
FCF Yield
+10.0%
EV/EBITDA
7.56

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.95B$612.10M$9.82
2024$2.74B$442.59M$6.97
2023$2.38B$338.30M$5.32
2022$2.18B$265.94M$4.17
2021$1.92B$199.22M$3.15

Social Signal Score

57
5d
57
1 mentions
30d
57
1 mentions
60d
57
1 mentions
90d
57
1 mentions
news: 1

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $2.77 per share

7of 7 quarters beat consensus

Typical surprise +1.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, Aug 5$2.70 vs $2.63beat
  • Wed, May 6$2.64 vs $2.52beat
  • Thu, Feb 19$3.24 vs $3.21beat
  • Thu, Nov 13$3.18 vs $3.17beat
  • Thu, Aug 14$3.01 vs $2.99beat
  • Thu, May 15$2.87 vs $2.84beat

Estimates and results for NICE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by NICE officers and directors.

Bought

0 trades

Sold
$50k

1 trade

  • Dayan Udi Yehudasold
    VP, Corporate Finance·500 @ $100.00·$50k·Aug 7, 2026·filing

99 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from NICE's reported EPS growth of 32.9% a year over 4 years. Historical EPS growth of 33% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.

EPS in 5 years
$36.46
Implied price
$437.53
Return from $102.26
33.7% a year

To earn 15.0% a year on these assumptions you'd need to buy at $217.53 — today's price is already 53.0% below that.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E810121416
20.0%13.8%19.0%23.5%27.3%30.8%
25.0%18.6%24.0%28.6%32.6%36.2%
30.0%23.3%29.0%33.7%37.9%41.7%
35.0%28.1%33.9%38.9%43.2%47.1%
40.0%32.8%38.9%44.0%48.5%52.6%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsseekingalpha.com·6h ago·Neutral

    NICE Posts Another Nice Earnings Beat, As AI-Driven Software Sees  Enterprise Demand NICE Ltd earns a buy rating, driven by AI-powered growth, global scale, and low leverage despite near-term earnings headwinds. NICE's CXone platform benefits from rising enterprise demand for AI-driven customer engagement, with proven global penetration and Fortune 100 clientele. Revenue diversification and steady 5-year growth differentiate NICE from smaller tech peers, though North American exposure remains a …

    View source ↗